π¨ Growth of Staphylococcus aureus in blood cultures should never be dismissed as a contaminant unless all causes are excluded and repeat cultures are negative. Always consider the possibility of endocarditis.
π About
- A common skin commensal with major pathogenic potential β causes mild to life-threatening infections.
- Produces numerous toxins (e.g. superantigens) that can trigger severe systemic immune responses.
π¬ Characteristics
- Gram-positive cocci in βgrape-likeβ clusters.
- Aerobic or facultative anaerobe; salt-tolerant (grows on mannitol salt agar).
- π§ͺ Coagulase-positive (key differentiator from coagulase-negative staphylococci).
- π§ͺ Catalase positive.
- Ξ²-haemolytic on blood agar.
- Surface protein A binds Fc region of IgG β blocks opsonisation and phagocytosis.
βοΈ Virulence Factors
- π§ͺ Coagulase β fibrin clot formation, immune evasion.
- π§ͺ Staphylokinase β dissolves clots, aids spread.
- π§ͺ Hyaluronidase β breaks down connective tissue.
- π§ͺ Haemolysins β RBC lysis.
- β οΈ PVL (Panton-Valentine leucocidin) β WBC destruction, aggressive skin infections.
- β‘ TSST-1 β superantigen, causes toxic shock syndrome.
- π₯ Exfoliative toxins β scalded skin syndrome.
- π‘οΈ Capsule β prevents phagocytosis.
π Source
- Carried in the nasal mucosa, skin, and moist body sites.
- Risk groups: healthcare workers, IV drug users, diabetics, immunocompromised patients.
β οΈ Pathogenicity
- π Food poisoning: Enterotoxins β rapid nausea, vomiting, abdominal pain (1β6 h post-ingestion).
- π©Ή Skin/soft tissue infections: Impetigo, boils, folliculitis, cellulitis, abscesses; toxins β scalded skin syndrome (Ritterβs).
- π¨ Toxic Shock Syndrome (TSS): Classically with tampon use or wound packing; TSST-1 triggers cytokine storm β shock, multiorgan failure.
- β€οΈ Endocarditis: Especially in IV drug users, prosthetic valves, indwelling IV catheters.
- 𦴠Osteomyelitis & π« Pneumonia: Post-influenza pneumonia is classic.
π Investigations
- Coagulase test: Positive.
- DNAse test: Positive (unlike CoNS).
- Mannitol salt agar: Grows well, golden-yellow colonies.
- Blood culture: Always significant unless proven otherwise.
- PCR/phage typing: for epidemiology/strain ID.
π Management
- MSSA (Methicillin-sensitive S. aureus):
- First-line: Flucloxacillin (UK). Cephalosporins or clindamycin if allergy.
- Other options: Fusidic acid (esp. skin infections), vancomycin if severe.
- MRSA (Methicillin-resistant S. aureus):
- Resistance due to mecA gene β altered PBP2a.
- First-line: IV vancomycin or teicoplanin.
- Alternatives: Linezolid, daptomycin (severe/systemic infections).
π§ͺ Sensitivity
- MSSA β sensitive to Ξ²-lactams (flucloxacillin, nafcillin).
- MRSA β requires glycopeptides (vancomycin/teicoplanin) or newer agents.